ACE2 as therapy for pulmonary arterial hypertension: the good outweighs the bad
Abstract
no abstract
Christophe Guignabert : Connect in order to contact the contributor
https://www.hal.inserm.fr/inserm-02582393
Submitted on : Thursday, May 14, 2020-9:41:08 PM
Last modification on : Monday, October 17, 2022-1:38:25 PM